US Market Opens Up For Henlius After First Shipment

Chinese Biosimilars Developer Marks Milestone Via Intas/Accord Partnership

Chinese biosimilars developer Henlius has celebrated its first shipment to the US, opening up a potentially lucrative market for the firm via local marketing partner Accord.

Doors are opening in the US for Henlius (Shutterstock)

More from Biosimilars

More from Generics Bulletin